A Multicenter Retrospective Study of Avelumab First-Line Maintenance and Subsequent Therapies for Locally Advanced and Metastatic Urothelial Carcinoma: Subgroup Analysis of First-Line Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, and Gemcitabine Plus Cisplatin in the Japan AVElumab MAintenance and Continuous Treatment Study (JAVEMACS)

Avelumab maintenance therapy is approved in Japan for patients with aUC without progression after PBC. This report presents subgroup analysis data from the JAVEMACS chart review of avelumab maintenance in patients who received 1L ddMVAC and GC. This retrospective study reviewed medical charts of pat...

Повний опис

Бібліографічні деталі

Автори:	Masaomi Ikeda, Kiyohide Fujimoto, Noriyoshi Miura, Rikiya Taoka, Kiyoaki Nishihara, Daiki Ikarashi, Sei Naito, Fumitaka Shimizu, Atsuko Fujihara, Michihiro Shono, Tohru Nakagawa, Eiji Kikuchi
Формат:	Artigo
Мова:	Inglês
Опубліковано:	MDPI AG 2025-11-01
Серія:	Current Oncology
Предмети:	treatment patterns ddMVAC GC avelumab enfortumab vedotin urothelial carcinoma
Онлайн доступ:	https://www.mdpi.com/1718-7729/32/11/618
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!